Progenesis is a San Diego-based company founded in 2015 that develops and offers non-invasive genetic tests
for patients on their family planning journey. We offer a variety of services that can be customized to meet
the needs of every patient we serve. The Progenesis team is a motivated group of genetic specialists,
researchers, laboratory professionals, and analysts who are passionate about improving our patients' lives.
As pioneers in genetic screening technologies, our scientists are constantly pursuing research initiatives
to advance our services and expand our understanding of human genetics.
Address: 4150 Regents Park Row Suite 245
La Jolla, CA 92037
Previda®-DX is designed to identify single gene defects in embryos prior to implantation. Single gene disorders are genetic conditions caused by a change or mutation in a specific gene. Individuals with a family history of a genetic condition may be at risk of passing the condition on to their children.
Preimplantation genetic testing for monogenic/single gene disorders (PGT-M) is recommended for parents undergoing IVF who are at high risk of passing a genetic condition to their offspring. Your results from the Previda®-DX test can allow your physician to select and transfer the embryo that is free of a specific single gene mutation.
Examples of common single gene disorders include:
Sickle cell anemia
Duchenne muscular dystrophy
Spinal muscular atrophy
Couples that have experienced recurrent miscarriages or unsuccessful pregnancies may be carriers of chromosomal structural rearrangements (translocations). In these cases, Previda®-DX can help reduce the risk of miscarriage by screening for embryos with unbalanced translocations and selecting embryos with a normal karyotype.